Machine Learning CytoReason to License Its IBD Disease Model to Sanofi in Expanded Multiyear, Multimillion Dollar… AIT News Desk Jan 23, 2023 CytoReason, a leader and pioneer in computational disease modeling, announced an expansion of its collaboration with Sanofi. The multiyear…
Machine Learning Tempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung Cancer AIT News Desk Jan 5, 2023 Tempus, a leader in artificial intelligence and precision medicine, announced a prospective study , in collaboration with AstraZeneca , that aims to…
Machine Learning Perceiv AI Announces an Investment of $1.5 Million from Strategic and Institutional Investors to… AIT News Desk Dec 9, 2022 Perceiv AI announced the closing of an investment of $1.5 Million. Perceiv AI is a precision medicine company optimizing and de-risking clinical…
Machine Learning Exscientia and MD Anderson Launch Strategic Collaboration to Leverage AI in Developing Novel… AIT News Desk Nov 14, 2022 Effort aligns MD Anderson’s drug development expertise with Exscientia’s AI-driven patient-first precision medicine and drug discovery platforms…
Machine Learning PathAI to Present on AI Models Supporting Advances in Oncology Research AIT News Desk Nov 8, 2022 PathAI, a leading provider of AI-powered pathology tools to advance precision medicine, announced that the organization’s recent research will be…
Machine Learning Tempus Launches First Cardiology Prospective Study for Its AI-Enabled Predictive Tests AIT News Desk Nov 3, 2022 In collaboration with iRhythm, Tempus is studying its predictive, AI-enabled algorithmic tests via a network of researchers to determine the…
Machine Learning Tempus Announces Sequencing Collaboration With Lilly to Expand Access to Genomic Testing AIT News Desk Jun 10, 2022 Tempus, a leader in artificial intelligence and precision medicine, announced a new collaboration sponsored by Eli Lilly and Company designed to…
Healthcare Management GE Healthcare Advances the Future of Precision Medicine in Oncology with New Technology Partners at… AIT News Desk Jun 10, 2022 Collaborations demonstrate role as a core partner in multidisciplinary cancer care From early detection to remote monitoring and data…
Machine Learning AdhereTech and Massive Bio, Two of NYC Digital Health 100 most Promising Start-Ups, Announce… AIT News Desk Jun 8, 2022 Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric clinical trial enrollment for oncology, and…
Healthcare Management GRAIL and Ochsner Health Launch New Initiatives to Improve Cancer Detection Rates in Louisiana AIT News Desk Jun 3, 2022 GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, and Ochsner Health (Ochsner) announced a multi-faceted…